Immuneering (IMRX) Other Accumulated Expenses (2022 - 2026)

Immuneering's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $44191.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 21.83% year-over-year to $44191.0; the TTM figure through Mar 2026 stood at $44191.0 (down 21.83% YoY), while the FY2025 annual figure was $291513.0, up 24.76% from the prior year.
• Other Accumulated Expenses was $44191.0 for Q1 2026 at Immuneering, down from $291513.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $291513.0 in Q4 2025 to a low of $19796.0 in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $96526.3 across 5 years, with a median of $56531.0 in 2025.
• Biggest YoY gain for Other Accumulated Expenses was 1212.23% in 2023; the steepest drop was 44.23% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $19796.0 in 2022, then soared by 1212.23% to $259770.0 in 2023, then decreased by 10.05% to $233665.0 in 2024, then climbed by 24.76% to $291513.0 in 2025, then plunged by 84.84% to $44191.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $44191.0 (Q1 2026), $291513.0 (Q4 2025), and $80089.0 (Q3 2025), per Business Quant data.